IHS Chemical Week

People & Business :: People/Executives

Codexis CEO Resigns

9:40 AM MST | February 21, 2012 | Rebecca Coons

Codexis CEO Alan Shaw resigned from his long-standing position at the enzyme developer to “pursue other interests,” sending stock prices 16% lower, to $3.81/share. Shaw has been with Codexis since its founding and was named CEO in 2002. He also led the enzyme maker through its 2010 initial public offering. Former senior v.p. and head of pharmaceuticals Peter Strumph will serve as interim CEO. Shaw’s departure closely follows news that CFO Bob Lawson will leave the company in following the company’s annual report filing. Market sources...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa